Results 201 to 210 of about 338,947 (383)
ABSTRACT Background Mycosis fungoides (MF) requires accurate clinical assessment for staging and management. Teledermatology aids remote evaluations, but there is limited data on the use of 3D total body photography (TBP) in assessing MF. Objective This study evaluates the accuracy and reliability of assessing a patient with MF using 3D TBP compared to
Kelvin Truong+6 more
wiley +1 more source
Leukocyte Migration Inhibition Factor in Atopic Dermatitis: Induction by Concanavalin A in Vitro
Maija Horsmanheimo, Aulis Horsmanheimo
openalex +1 more source
ABSTRACT Background Atopic dermatitis (AD) significantly impacts quality of life, with well‐documented physical and psychological consequences. While disease burden is well characterised, the influence of psychosocial determinants on AD outcomes remains underexplored. This study examines these factors in an Australian paediatric population.
Ashling Courtney+5 more
wiley +1 more source
MOMETAZON FUROAT FOR ATOPIC DERMATITIS IN CHILDREN
Atopic dermatitis is one of the most prevalent reasons for skin lesions in the infancy. The medications of the first line therapy for this disease are topic glucocorticosteroids (TGCS).
T.S. Shaipov, L.P. Mazitova
doaj
Occurrence of Malignant Neoplasms in Patients with Atopic Dermatitis
K Kaaber
openalex +2 more sources
ABSTRACT Background/Objectives Janus kinase inhibitors (JAKis) have been approved by the Therapeutic Goods Administration for severe alopecia areata (AA) in Australia. However, access is limited as JAKis are not currently subsidised on the Pharmaceutical Benefits Scheme for this indication. This study aimed to establish expert consensus on criteria for
Meryl Thomas+23 more
wiley +1 more source
Role of immediate food hypersensitivity in the pathogenesis of atopic dermatitis
Hugh A. Sampson
openalex +1 more source
Cutaneous and mucosal manifestations associated with celiac disease [PDF]
Beteta Gorriti, Valia Patricia+6 more
core +2 more sources
Retrospective Review on Safety and Efficacy of Combination Biologic Therapy for Psoriasis
ABSTRACT Background There is limited data on the use of dual or combination biologic therapy in dermatological patients, particularly in psoriasis or with other coexisting dermatological conditions. However, this may be necessary for a small proportion of patients.
Nicole Kah Mun Yoong+2 more
wiley +1 more source